RAPP Insider Trading Activity and SEC Form 4 Filings
RAPP insider trading summary
Over the past 12 months, insiders at Rapport Therapeutics, Inc. (RAPP) reported 91 sales worth $217.6M by 10 insiders and 11 open-market purchases worth $22.0M by 7 insiders on SEC Form 4. Net insider selling was $195.6M.
Latest RAPP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 28, 2026 | James Healy | Director | Buy | $79K (3,772 @ $21.00) |
| Oct 28, 2026 | James Healy | Director | Buy | $134K (6,395 @ $21.00) |
| Oct 28, 2026 | James Healy | Director | Buy | $20.0M (952,380 @ $21.00) |
| Oct 28, 2026 | James Healy | Director | Buy | $146K (6,933 @ $21.00) |
| Oct 23, 2026 | Ramiro Sanchez | Insider | Buy | $98K (3,600 @ $27.35) |
| Oct 22, 2026 | John Maraganore | Insider | Buy | $32K (1,172 @ $26.92) |
| Oct 22, 2026 | Paul M Silva | Insider | Buy | $100K (3,680 @ $27.07) |
| Oct 22, 2026 | John Maraganore | Insider | Buy | $217K (8,239 @ $26.38) |
| Oct 22, 2026 | Steven M Paul | Insider | Buy | $974K (35,714 @ $27.28) |
| Oct 22, 2026 | Wendy B. Young | Insider | Buy | $100K (3,789 @ $26.39) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.